These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11570357)

  • 1. 'Prevention doesn't pay?' Logic explodes this myth.
    Victoroff MS
    Manag Care; 2001 Sep; 10(9):56-7. PubMed ID: 11570357
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and cost containment.
    Susser M
    Bull N Y Acad Med; 1980; 56(1):45-52. PubMed ID: 6766765
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in disease prevention: assessing the benefits of prevention.
    McGinnis JM
    Bull N Y Acad Med; 1980; 56(1):38-44. PubMed ID: 6766764
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventive care and practice funding.
    Frankford R
    CMAJ; 1990 Jun; 142(12):1363. PubMed ID: 2350756
    [No Abstract]   [Full Text] [Related]  

  • 5. Public health in crisis: the economic consequences of inaction on preventive medicine.
    Fahs MC
    Mt Sinai J Med; 1992 Nov; 59(6):469-78. PubMed ID: 1480200
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiological issues in health promotion and cost containment.
    Philips BV
    Health Values; 1988; 12(5):32-8. PubMed ID: 10312674
    [No Abstract]   [Full Text] [Related]  

  • 7. The attorney-client privilege: what it does and doesn't cover.
    Caesar N
    Manag Care; 1996 Jul; 5(7):59-60. PubMed ID: 10159325
    [No Abstract]   [Full Text] [Related]  

  • 8. Six keys to cost-effective health care.
    Palsbo SE
    J Health Care Benefits; 1994; 4(2):46-50. PubMed ID: 10154527
    [No Abstract]   [Full Text] [Related]  

  • 9. Achieving cost-effective practice in a prepaid plan.
    Tillotson JK; Meier G
    Med Group Manage; 1979; 26(3):44, 46, 48-9. PubMed ID: 10308928
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the vested interests on the adoption of a new technology.
    Oldfield HR
    Med Instrum; 1979; 13(1):20-1. PubMed ID: 106227
    [No Abstract]   [Full Text] [Related]  

  • 11. HMO performance: current knowledge and questions for the 1980s. A research agenda considered.
    Luft H
    Group Health J; 1980; 1(1):34-40. PubMed ID: 10309236
    [No Abstract]   [Full Text] [Related]  

  • 12. The bottom line: HMO and rehabilitation.
    Cromer M
    Rehab Manag; 1998; 11(4):54-5. PubMed ID: 11066855
    [No Abstract]   [Full Text] [Related]  

  • 13. Getting serious about generics.
    Sipkoff M
    Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
    [No Abstract]   [Full Text] [Related]  

  • 14. HMOs today.
    Arkans HD
    N J Med; 1991 Jun; 88(6):395-6. PubMed ID: 1886697
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-funded HMOs on the rise.
    Baker S
    Manag Care; 2002 May; 11(5):46D, 46F, 46H. PubMed ID: 12061160
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating technology and disease management--the challenges.
    Baker GB
    Healthplan; 2002; 43(5):60-2, 64-6. PubMed ID: 12387154
    [No Abstract]   [Full Text] [Related]  

  • 17. [Yes to health economics].
    Alfonso Sánchez JL
    Med Clin (Barc); 1989 May; 92(20):776-9. PubMed ID: 2507839
    [No Abstract]   [Full Text] [Related]  

  • 18. Either way ... you pay. Medicare HMOs seek more out-of-pocket payments.
    Benko LB
    Mod Healthc; 2003 Sep; 33(37):8-9, 13. PubMed ID: 14520919
    [No Abstract]   [Full Text] [Related]  

  • 19. Promoting economic value in public health.
    Leidl R
    Eur J Public Health; 2008 Jun; 18(3):216. PubMed ID: 18504273
    [No Abstract]   [Full Text] [Related]  

  • 20. The philosophy of Preventive Medicine.
    Smith JE
    Minn Med; 1976 Mar; 59(3):196-9. PubMed ID: 1256428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.